A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Esophageal Squamous Cell Carcinoma
- Type
- Interventional
- Phase
- Early Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03940001
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: chen ming, MD Zhejiang Cancer Hospital Principal Investigator: chen qixun, MD Zhejiang Cancer Hospital
Get Well Soon